image: The molecule IL-11 promoted fibrotic pathways (green) in human lung cells, although less than TGF-beta 1. This material relates to a paper that appeared in the Sept. 25, 2019, issue of Science Translational Medicine, published by AAAS. The paper, by B. Ng at National Heart Centre Singapore in Singapore, Singapore; and colleagues was titled, "Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis." view more
Credit: Credit: B. Ng <i>et al., Science Translational Medicine</i> (2019)